Viron To Present Data From Phase II Trial At American Heart Association Conference
Posted by: DrugsNews on: 12 Nov, 2009
Viron To Present Data From Phase II Trial At American Heart Association Conference
Viron Therapeutics Inc., a biopharmaceutical company pioneering the development of viral protein therapeutics, announced that the Company’s research collaborator, Dr. Jean-Claude Tardif, Director of the Research Center at the Montreal Heart Institute, will present data from a Phase IIa clinical trial evaluating VT-111 at the American Heart Association (AHA) Scientific Sessions 2009 conference.
Read more about Viron To Present Data From Phase II Trial At American Heart Association Conference
| Indian Pharmacy! Looking for Generic Medications? Quality Drugs at affordable prices! Reliable Indian Pharmacy www.IndianPharmacy.org |
#1 Canadian Pharmacy Online! The Lowest Prices from Canadian Drugstore! Various payments, secure shopping, worldwide shipping! www.CanadianPharmacyLtd.org |
What are the Drugs-Review websites?
The Drugs-Review websites are NOT but will be your number one stop for all the latest news, comment and pharmaceutical industry information.
Related posts:
- Viron to Present Data from Phase II Trial at American Heart Association Conference
- Zargis To Release Trial Version Of Cardioscan While Exhibiting With 3M(TM) Littmann(R) At American Heart Association Conference
- AVANIR to Present Pivotal Zenvia Phase III Data at American Neurological Association and World Congress on Controversies in Neurology Annual Meetings
